Pfizer Inc.

NYSE:PFE

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

💉 Vaccines

Location

United States

Market Cap

USD 140.15 B

Share Price

USD 24.65

Avg Daily Volume

41,828,068

Change (1 day)

0.29%

Change (1 year)

-13.36%

Change (YTD)

-7.09%

Pfizer Inc. EBITDA for the Trailing 12 Months (TTM) ending June 29, 2025: USD 22.77 B

Pfizer Inc. EBITDA is USD 22.77 B for the Trailing 12 Months (TTM) ending June 29, 2025, a 315.15% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Pfizer Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 5.49 B, a -81.70% change year over year.
Pfizer Inc. EBITDA for the Trailing 12 Months (TTM) ending July 02, 2023 was USD 29.99 B, a -21.91% change year over year.
Pfizer Inc. EBITDA for the Trailing 12 Months (TTM) ending July 03, 2022 was USD 38.40 B, a 92.61% change year over year.
Pfizer Inc. EBITDA for the Trailing 12 Months (TTM) ending July 04, 2021 was USD 19.94 B, a -9.26% change year over year.